Content about Kidney

April 22, 2011
Study: Pirfenidone could improve kidney function among diabetic nephropathy patients

An investigational antifibrotic and anti-inflammatory drug could help treat a common complication of diabetes.

NEW YORK — An investigational antifibrotic and anti-inflammatory drug could help treat a common complication of diabetes.

Researchers at the University of California-San Diego School of Medicine, the National Institutes of Health and the Mayo Clinic found that pirfenidone potentially could treat diabetic nephropathy, a leading cause of end-stage kidney disease.

February 25, 2011
Type 1 diabetics continue to be at risk for kidney disease

Advances in kidney care have not led to successful efforts to improve therapy for patients with Type 1 diabetes, according to a study published in the Journal of the American Society of Nephrology.

BOSTON — Advances in kidney care have not led to successful efforts to improve therapy for patients with Type 1 diabetes, according to a study published in the Journal of the American Society of Nephrology.

February 16, 2011
Amicus' Amigal improves symptoms among Fabry disease patients in trial

Amicus Therapeutics received good results from its mid-stage trial of a drug for a rare, genetic disorder, the drug maker said Wednesday.

CRANBURY, N.J. — Amicus Therapeutics received good results from its mid-stage trial of a drug for a rare, genetic disorder, the drug maker said Wednesday.